Skip to main content

LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE

NDC 31722-755 · Camber Pharmaceuticals, Inc.

Generic nameLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE
Strength12.5; 50 mg/1; mg/1
Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
Marketing categoryANDA

Packages

31722-755-10 — 1000 TABLET, FILM COATED in 1 BOTTLE (31722-755-10)

31722-755-30 — 30 TABLET, FILM COATED in 1 BOTTLE (31722-755-30)

31722-755-90 — 90 TABLET, FILM COATED in 1 BOTTLE (31722-755-90)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

29300-192 — losartan potassium and hydrochlorothiazide, 29300-215 — Irbesartan and Hydrochlorothiazide, 29300-216 — Irbesartan and Hydrochlorothiazide, 29300-485 — Hydrochlorothiazide, 30698-452 — benazepril hydrochloride and hydrochlorothiazide, 30698-453 — benazepril hydrochloride and hydrochlorothiazide, 30698-454 — benazepril hydrochloride and hydrochlorothiazide, 31722-700 — Losartan Potassium, 31722-701 — Losartan Potassium, 31722-702 — Losartan Potassium, 31722-756 — LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, 31722-757 — LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, 31722-886 — Olmesartan medoxomil and hydrochlorothiazide, 31722-887 — Olmesartan medoxomil and hydrochlorothiazide, 31722-888 — Olmesartan medoxomil and hydrochlorothiazide, 31722-892 — Olmesartan medoxomil, amlodipine and hydrochlorothiazide, 31722-893 — Olmesartan medoxomil, amlodipine and hydrochlorothiazide, 31722-894 — Olmesartan medoxomil, amlodipine and hydrochlorothiazide, 31722-895 — Olmesartan medoxomil, amlodipine and hydrochlorothiazide, 31722-896 — Olmesartan medoxomil, amlodipine and hydrochlorothiazide, +1060 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels